Science as the Foundation

Innovation Leads the Way

Fannkoer Biotech (Zhongshan) Co., Ltd. was established in 2019 by leading experts from the biopharmaceutical industry and clinical oncology. As a high-tech innovative biopharmaceutical company, it is driven by exceptional independent R&D capabilities at its core, possessing comprehensive capabilities in preclinical research, translational medicine, and clinical studies. The company has established platforms for targeted drug development, radiopharmaceutical conjugates, and boron neutron capture therapy. Its product pipeline focuses on areas with significant unmet clinical needs, including lung cancer, gastric cancer, and urological tumors, aiming to develop breakthrough potential first-in-class or best-in-class drugs for the global market.

The company has built a laboratory exceeding 1000㎡, covering medicinal chemistry, pharmacological efficacy, drug analysis, and pharmaceutical formulation laboratories.